Soligenix, Inc. Common Stock
Symbol: SNGX (NASDAQ)
1.20
▼ (-25.80%) -0.418
Company Description:
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
Key Stats
- Today's Open: $1.19
- Today's High: $1.86
- Today's Low: $1.115
- Today's Volume: 5.90M
- Yesterday Close: $1.62
- Yesterday High: $1.8
- Yesterday Low: $1.6101
- Yesterday Volume: 1.00M
- Last Min Volume: 12.14K
- Last Min High: $1.215
- Last Min Low: $1.205
- Last Min VWAP: $1.21253
Company Profile
- Name: Soligenix, Inc. Common Stock
- Website: https://www.soligenix.com
- Listed Date: 1994-04-05
- Location: PRINCETON, NJ
- Market Status: Active
- CIK Number: 0000812796
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.94M
- Round Lot: 100
- Outstanding Shares: 4.29M
- Asset Type: CS
RECENT FILINGS FOR SNGX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-25 | EFFECT | View |
| 2025-09-19 | S-1 | View |
| 2025-08-27 | DRS | View |
| 2025-08-18 | 8-K | View |
| 2025-08-15 | 424B3 | View |
| 2025-08-15 | 8-K | View |
| 2025-08-15 | 424B3 | View |
| 2025-08-15 | 424B3 | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | S-8 | View |
| 2025-06-20 | 8-K | View |
| 2025-05-09 | 10-Q | View |
| 2025-05-05 | ARS | View |
| 2025-05-05 | DEFA14A | View |
| 2025-05-05 | DEF 14A | View |
Latest News on SNGX